Z-AC4C-OH
Need Assistance?
  • US & Canada:
    +
  • UK: +

Z-AC4C-OH

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
CBZ-Amino Acids
Catalog number
BAT-005276
CAS number
190004-53-6
Molecular Formula
C13H15NO4
Molecular Weight
249.26
Z-AC4C-OH
IUPAC Name
1-(phenylmethoxycarbonylamino)cyclobutane-1-carboxylic acid
Synonyms
1-(Benzyloxycarbonylamino)-cyclobutyl-1-carboxylic acid; 1-(Z-amino)cyclobutanecarboxylic acid; 1-(Z-amino)-cyclobutyl-1-carboxylic acid; Z-ACBC-OH; Z-cyclovaline
Appearance
White crystalline powder
Purity
≥ 99% (HPLC)
Density
1.290 g/cm3
Melting Point
64-94 °C
Boiling Point
458.2 °C at 760 mmHg
Storage
Store at 2-8 °C
InChI
InChI=1S/C13H15NO4/c15-11(16)13(7-4-8-13)14-12(17)18-9-10-5-2-1-3-6-10/h1-3,5-6H,4,7-9H2,(H,14,17)(H,15,16)
InChI Key
GDJSFBNRXFOUEQ-UHFFFAOYSA-N
Canonical SMILES
C1CC(C1)(C(=O)O)NC(=O)OCC2=CC=CC=C2
1. Conformational restriction through C alpha i <--> C alpha i cyclization: Ac12c, the largest cycloaliphatic C alpha,alpha- disubstituted glycine known
M Saviano, R Iacovino, V Menchise, E Benedetti, G M Bonora, M Gatos, L Graci, F Formaggio, M Crisma, C Toniolo Biopolymers. 2000 Feb;53(2):200-12. doi: 10.1002/(SICI)1097-0282(200002)53:23.0.CO;2-L.
Two complete series of N-protected, monodispersed oligopeptide esters to the pentamer level from 1-aminocyclododecane-1-carboxylic acid (Ac(12)c), an alpha-amino acid conformationally constrained through C(alpha)(i) <--> C(alpha)(i) cyclization, and either L-Ala or Aib residues, along with the N-protected Ac(12)c homopeptide alkylamide series from monomer to trimer, have been synthesized by solution methods and fully characterized. The solution-preferred conformations of these peptides have been assessed by Fourier transform ir absorption and (1)H-nmr techniques. Moreover, the molecular structures of one derivative (Z-Ac(12)c-OH) and three peptides [the tripeptide ester Z-L-Ala-Ac(12)c-L-Ala-OMe, the tripeptide alkylamide Z-(Ac(12)c)(3)-NHiPr, and the tetrapeptide ester Z-(Aib)(2)-Ac(12)c-Aib-OtBu (Aib, alpha-aminoisobutyric acid)] have been determined in the crystal state by x-ray diffraction. The results obtained point to the conclusion that beta-bends and 3(10)-helices are preferentially adopted by peptides based on Ac(12)c, the largest cycloaliphatic C-disubstituted glycine known. A comparison with the structural tendencies extracted from published works on peptides from Aib, the prototype of C-disubstituted glycines, and the other extensively studied members of the class of 1-aminocycloalkane-1-carboxylic acids (Ac(n) c, with n = 3-9), is made and the implications for the use of the Ac(12)c residue in the Ac(n) c scan approach of conformationally restricted analogues of bioactive peptides are briefly discussed.
2. Preferred conformation of peptides rich in Ac8c, a medium-ring alicyclic C (alpha,alpha)-disubstituted glycine
V Moretto, F Formaggio, M Crisma, G M Bonora, C Toniolo, E Benedetti, A Santini, M Saviano, B Di Blasio, C Pedone J Pept Sci. 1996 Jan-Feb;2(1):14-27. doi: 10.1002/psc.43.
A complete series of terminally blocked, monodispersed homo-oligopeptides (to the pentamer level) from the sterically demanding, medium-ring alicyclic C (alpha,alpha)-disubstituted glycine 1-aminocyclooctane-1-carboxylic acid (Ac8c), and two Ala/Ac8c tripeptides, were synthesized by solution methods and fully characterized. The preferred conformation of all the oligopeptides was determined in deuterochloroform solution by IR absorption and 1H-NMR. The molecular structures of the amino acid derivative Z-Ac8c-OH, the dipeptide pBrBz-(Ac8c)2-OH and the tripeptide pBrBz-(Ac8c)3-OtBu were assessed in the crystal state by X-ray diffraction. Conformational energy computations were performed on the monopeptide Ac-Ac8c-NHMe. Taken together, the results obtained strongly support the view that the Ac8c residue is an effective beta-turn and helix former. A comparison is also made with the conformational preferences of alpha-aminoisobutyric acid, the prototype of C (alpha,alpha)-disubstituted glycines, and of the other members of the family of 1-aminocycloalkane-1-carboxylic acids (Acnc with n = 3, 5-7) investigated so far. The implications for the use of the Ac8c residue in peptide conformational design are considered.
3. Conformational characterization of peptides rich in the cycloaliphatic C alpha,alpha-disubstituted glycine 1-aminocyclononane-1-carboxylic acid
M Gatos, F Formaggio, M Crisma, G Valle, C Toniolo, G M Bonora, M Saviano, R Iacovino, V Menchise, S Galdiero, C Pedone, E Benedetti J Pept Sci. 1997 Sep-Oct;3(5):367-82. doi: 10.1002/(SICI)1099-1387(199709)3:5%3C367::AID-PSC116%3E3.0.CO;2-V.
A series of N- and C-protected, monodispersed homo-oligopeptides (to the pentamer level) from the cycloaliphatic C alpha,alpha-dialkylated glycine 1-aminocyclononane-1-carboxylic acid (Ac9c) and two Ala/Ac9c tripeptides have been synthesized by solution methods and fully characterized. The conformational preferences of all the model peptides were determined in deuterochloroform solution by FT-IR absorption and 1H-NMR. The molecular structures of the amino acid derivatives mCIAc-Ac9c-OH and Z-Ac9c-OtBu, the dipeptide pBrBz-(Ac9c)2-OtBu, the tetrapeptide Z-(Ac9c)4-OtBu, and the pentapeptide Z-(Ac9c)5-OtBu were determined in the crystal state by X-ray diffraction. Based on this information, the average geometry and the preferred conformation for the cyclononyl moiety of the Ac9c residue have been assessed. The backbone conformational data are strongly in favour of the conclusion that the Ac9c residue is a strong beta-turn and helix former. A comparison with the structural propensity of alpha-aminoisobutyric acid, the prototype of C alpha,alpha-dialkylated glycines, and the other extensively investigated members of the family of 1-aminocycloalkane-1-carboxylic acids (Acnc, with n = 3-8) is made and the implications for the use of the Ac9c residue in conformationally constrained analogues of bioactive peptides are briefly examined.
Online Inquiry
Verification code
Inquiry Basket